PathoQuest
PathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS).
PathoQuest has raised €19M across 2 funding rounds from 9 investors, most recently a Series B round in Nov 2021. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€19M
€19,464,000
Funding rounds
2
Investors
9
distinct backers
Active since
2013-07
latest 2021-11
Funding by year
EUR raised per yearPathoQuest — funding by year — interactive chart.
Data table
| PathoQuest — funding by year | |
|---|---|
| 2013 | €4.5M |
| 2021 | €15M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-10 | Series B | €15M | Aurinvest,Charles River Laboratories,Eurazeo,Kurma Partners,Sham,SHS Capital+2 more | View deal → |
| 2013-07-01 | Other | €4.5M | IDInvest Partners | View deal → |
Investors
9Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData